A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study is designed to compare the effects of nebivolol (10, 20, 40mg/day) with another
beta blocker, extended-release metoprolol, at a range of doses. Its purpose is to study the
mechanism of action of nebivolol on forearm blood flow, nitric oxide availability and other
biomarkers.